RecruitingNot applicableNCT06883448
Implementation of Home Monitoring in Patients With Pulmonary Fibrosis
Studying Idiopathic pulmonary fibrosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Erasmus Medical Center
- Principal Investigator
- Marlies S. Wijsenbeek-Lourens, Prof DrDepartment of Respiratory Medicine, Center of Excellence for Interstitial Lung Disease, Erasmus University Medical Center, Rotterdam, The Netherlands
- Intervention
- Home monitoring care(combination_product)
- Enrollment
- 220 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2026
Study locations (11)
- Department of Pulmonology, Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands
- Department of Pulmonary Diseases, Rijnstate Hospital, Arnhem, Netherlands
- Department of Respiratory Medicine, Amphia Hospital, Breda, Netherlands
- Department of Respiratory Medicine, Catharina Hospital, Eindhoven, Netherlands
- Department of Pulmonary Medicine, Zuyderland Medical Centre, Heerlen, Netherlands
- Department of Pulmonology, Medical Center Leeuwarden, Leeuwarden, Netherlands
- Department of Pulmonology, Leiden University Medical Center, Leiden, Netherlands
- Interstitial Lung Diseases Center of Excellence, Department of Pulmonology, St Antonius Hospital, Nieuwegein, Netherlands
- Department of Respiratory Medicine, Center of Excellence for Interstitial Lung Disease, Erasmus University Medical Center, Rotterdam, Netherlands
- Department of Pulmonology, Haaglanden Medisch Centrum, The Hague, Netherlands
- Division of Heart and Lungs, University Medical Center Utrecht and Utrecht University, Utrecht, Netherlands
Collaborators
Zuyderland Medisch Centrum, Sittard-Geleen, the Netherlands · Leiden University Medical Center, LUMC, Leiden, The Netherlands · UMC Utrecht, Utrecht, the Netherlands · Rijnstate, Arnhem, the Netherlands · Catharina, Eindhoven, the Netherlands · MC Leeuwarden, Leeuwarden, the Netherlands · OLVG, Amsterdam, the Netherlands · Medical Center Haaglanden, The Hague, The Netherlands · Amphia, Breda, the Netherlands · St. Antonius Hospital
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06883448 on ClinicalTrials.govOther trials for Idiopathic pulmonary fibrosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT05988463Dose-Escalation Study of Artesunate Patients With IPFJoseph C. Wu
- RECRUITINGNANCT07482917Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 TrialHospital de Granollers
- RECRUITINGNANCT07486206Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 TrialHospital de Granollers
- RECRUITINGPHASE2NCT06241560A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the BloodBoehringer Ingelheim
- RECRUITINGPHASE3NCT07201922A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary FibrosisBoehringer Ingelheim
- RECRUITINGNANCT07466420Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases.Katerina M. Antoniou
- RECRUITINGPHASE3NCT07299695Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary FibrosisArgyrios Tzouvelekis
- RECRUITINGPHASE2NCT07284459Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary FibrosisContineum Therapeutics